Navigation Links
NephCure Foundation Announces Research Grant Program Recipients

Seven applicants receive a total of over $1.7 million

BERWYN, Pa., July 28 /PRNewswire-USNewswire/ -- The NephCure Foundation (NCF) has awarded more than $1.7 million to researchers in its 2009 Scientific Research Grant Program.

The announcement was made by Henry Brehm, NephCure Foundation's Executive Director and Dr. Lawrence Holzman, Chair of the NCF Scientific Advisory Board.

The Scientific Grant Program supports basic, transitional and clinical research initiatives to understand the cause, identify treatments and find the cure for primary focal segmental glomerulosclerosis (FSGS) and Nephrotic Syndrome (NS). To date, The NephCure Foundation has committed over $6 million to research and education, including $1.6 million for the 2008 Scientific Research Grant Program.

Post-Doctoral Fellowship grants were awarded to:

  • Sebastian Martini, M.D. of University of Michigan, Ann Arbor, MI
  • Hideki Kato, M.D., Ph.D. of Albert Einstein College of Medicine, Bronx, NY

Young Investigator Grants were awarded to:

  • Christian Faul, Ph.D. of University of Miami, Miami, FL
  • Valerie Anne Schumacher, Ph.D. of Children's Hospital Boston, Boston, MA
  • Kirk Campbell M.D. of University of Miami, Miami, FL
  • Mira Krendel, Ph.D. of SUNY Upstate Medical University, Syracuse, NY

Established Investigator New Direction Grant awarded to:

  • Sanja Sever, Ph.D. of Massachusetts General Hospital, Boston, MA

The NephCure Foundation launched the grant program in 2008, providing funding for basic, translational and clinical research into two potentially devastating kidney conditions, FSGS and NS. Since the inaugural year, the program has seen nearly a 150 percent increase in the number of applications received. This is indicative of NephCure's growth and increasing role as the leading advocate for research into NS and FSGS.

NS and FSGS are conditions that affect the tiny filtering units (glomeruli) in the kidney. The result is that protein needed by the body is discarded into the urine. Over time, these conditions can result in renal failure and the need for dialysis or a kidney transplant. The primary cause for most forms of NS and FSGS are not known and there is no cure.

The NephCure Foundation has a unique challenge in identifying patient families. Privacy laws preclude doctors from providing information and because FSGS and NS are invisible, people tend to struggle with them silently. Therefore, NephCure uses publicity and public service announcements to find people suffering from the diseases.

SOURCE NephCure Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
2. Dr. Christopher Olivia Appointed to Foundation Radiology Group Board of Directors
3. Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week
4. Foundation Radiology Group Builds Sales and Marketing Teams for Projected Record-Year Growth
5. National Science Foundation Announces $20M Research Award to South Carolina
6. Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinsons Drug Development
7. The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers
8. The Maurer Foundation for Breast Health Education Launches Integrated Rebranding Operation
9. American Health Assistance Foundation & Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Project
10. TCS Healthcare Technologies Provides $5,000 Seed Money to Help Fund New CMSA Foundation
11. Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St. Louis, Mo.
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: